Clinical Trial Update: Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on cranial radiotherapy combined with chemoimmunotherapy for untreated driver-mutation negative non-small cell lung cancer with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Snippet

Sponsor: Fudan University | Conditions: NSCLC Stage IV, Brain Metastases | Phase 2 | Status: RECRUITING